Mechelen, Belgium, 20 October 2023 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company, announces that four study abstracts on Idylla™ have been selected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback